Characterization of an in vivo concentration-effect relationship for piperaquine in malaria chemoprevention. by Bergstrand, M, Nosten, F, Lwin, K, Karlsson, M, White, N, Tarning, J

Prediction of improved antimalarial chemoprevention with weekly dosing of dihydroartemisinin-piperaquine. by Permala, J, Tarning, J, Nosten, F, White, N, Karlsson, M, Bergstrand, M

Population pharmacokinetic and pharmacodynamic properties of artesunate in patients with artemisinin sensitive and resistant infections in Southern Myanmar by Das, J, Kyaw, M, Nyunt, M, Chit, K, Aye, K, Aye, M, Karlsson, M, Bergstrand, M, Tarning, J

Population pharmacokinetic and pharmacodynamic modeling of artemisinin resistance in Southeast Asia by Lohy Das, J, Dondorp, A, Nosten, F, Phyo, A, Hanpithakpong, W, Ringwald, P, Lim, P, White, N, Karlsson, M, Bergstrand, M, Tarning, J

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy. by Tarning, J, Chotsiri, P, Jullien, V, Rijken, M, Bergstrand, M, Cammas, M, Mcgready, R, Singhasivanon, P, Day, N, White, N, Nosten, F, Lindegardh, N

Population pharmacokinetic and pharmacodynamic modeling of amodiaquine and desethylamodiaquine in women with Plasmodium vivax malaria during and after pregnancy by Tarning, J, Chotsiri, P, Jullien, V, Rijken, M, Bergstrand, M, Cammas, M, McGready, R, Singhasivanon, P, Day, N, White, N, Nosten, F, Lindegardha, N

External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients. by Rekić, D, Röshammar, D, Bergstrand, M, Tarning, J, Calcagno, A, D'Avolio, A, Ormaasen, V, Vigan, M, Barrail-Tran, A, Ashton, M, Gisslén, M, Äbelö, A